TrialJournal of gastroenterology2015

Vaniprevir plus peginterferon alfa-2a and ribavirin in treatment-experienced Japanese patients with hepatitis C virus genotype 1 infection: a randomized phase II study.

Norio Hayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.